Global Orthobiologics Market
Orthobiologics Market - Global Industry Size, Share, Trend Analysis and Forecast Report, 2018-2028, Segmented By Product (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-Rich Protein, Bone Marrow Aspirate Concentrate), By Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications), By End User (Hospitals, Orthopedic Clinics, & Ambulatory Care Centers, Research & Academic Institutes, Dental Clinics and Facilities), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA)
- Published Date: May 2022
- Report ID: BWC22155
- Available Format: PDF
- Page: 400
Report Overview
The global orthobiologics market flourishing at a high rate owing to the increasing prevalence of broken bones and injured muscles, tendons, and ligaments due to changing lifestyles and the increasing rate of road and other types of accidents...
Global Orthobiologics Market- Industry Trends & Forecast Report 2028
The global orthobiologics market was worth USD 6.2 billion in 2021 and is further projected to reach USD 8.8 billion by the year 2028, growing at a CAGR of 5.20% during the forecast period. The global orthobiologics market is flourishing at a high rate owing to the increasing prevalence of broken bones and injured muscles, tendons, and ligaments due to changing lifestyles and the increasing rate of road and other types of accidents. The rising adoption of orthobiologics among athletes is also driving the growth of the market.
Orthobiologics - Overview
Orthobiologics are biological substances that are used to help injuries heal more quickly. These substances are often made from products that are naturally found in the body. Orthobiologics helps in boosting the healing process of injuries. This kind of procedure plays an important role in avoiding invasive treatment methods. These substances are injected into the affected areas in higher concentrations to help with the treatment.
Orthobiologics Market Forecast and Trends
Growth Drivers
Increasing Rate of Road and Other Accidents
The concerning surge in the rate of road and other types of accidents that physically affects the body is emerging as the major driving factor for the global orthobiologics market. According to a report by the World Health Organization, around 20 to 50 million people suffer from non-fatal and fatal injuries during a road traffic crash every year. Due to this, the demand in the global orthobiologics market is surging for effective and faster treatment.
Extensive Research and Development Activities
With the expanding scope of the global orthobiologics market, the research institutes and pharmaceutical industry are significantly investing and focusing on R&D activities in this field. The research conducted is mainly focused on developing new products and expanding the application of the orthobiologics market. Several studies are also undergoing in this field. For instance, Sanford Health is conducting research to study the potential of orthobiologics and regenerative medicine for people with osteoarthritis.
Restraints
High Cost of Orthobiologics
The high cost of orthobiologics acts as a major restraining factor for the growth of the market. According to a report by the Foundation for Orthopedic Research and Education (FORE), the cost of two orthobiologics, platelet-rich pharma injections, and stem cell injections ranges from around a few hundred dollars to as much as USD 12,000 per treatment. Therefore, orthobiologics treatment is still concentrated among western countries with the development of healthcare infrastructure and high disposable income groups.
Orthobiologics Market - By Product
Based on product, the global orthobiologics market is segmented into viscosupplementation products, demineralized bone matrices, synthetic orthobiologics, bone morphogenic protein, allografts, plasma-rich protein, and bone marrow aspirate concentrate. The viscosupplementation products hold the largest share in the market. On account for a wide range of goods available and their unparalleled popularity in conditions like osteoarthritis and hip degenerative joint disease, these products have a high adoption rate.
Orthobiologics Market - By Application
Based on application, the global orthobiologics market is segmented into osteoarthritis and degenerative arthritis, spinal fusion, soft-tissue injuries, fracture recovery, and maxillofacial and dental applications. Spinal fusion accounts for the largest market share because of its potential to give high bone stability and rapid bone healing, consistent penetration of demineralized bone matrices, bone morphogenetic proteins, autografts, and allografts in spinal fusion procedures has been found to improve long-term spinal problems.
Orthobiologics Market - Regional Insights
Geographically, the global orthobiologics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. North America dominates the orthobiologics market owing to the developed healthcare infrastructure and high adoption of advanced treatment methods in healthcare facilities. Furthermore, the presence of leading industry players and favorable reimbursement policies also play a crucial role in driving market growth. However, the Asia-Pacific region is projected to witness the highest growth rate during the forecast period.
Competitive Landscape
The leading market players of the global orthobiologics market are Arthrex Inc., Seaspine Holdings Corporation, Sanofi, Bone Support, DePuy Synthes, Integra Lifesciences, Globus Medical Inc., NuVasive Inc., Terumo Corporation, Medtronic PLC, Stryker Corporation, Zimmer Biomet, Pioneer Surgical Technology, Smith & Nephew plc, Bioventus LLC, Orthofix, Inc., Genzyme, Bone Biologics, Corp., Osiris Therapeutics, Inc., and other prominent players.
The market is highly competitive with the presence of several multinational corporations and industrial giants. These companies significantly invest in research and development activities to introduce innovations into their offerings and are constantly launching new products. The adoption of competitive strategies such as partnerships, mergers, acquisitions, collaborations, etc., is also prominent in this market.
Recent Development
-
In March 2022, SeaSpine Holding, a US-based advanced spinal cord technologies company, announced the launch of new orthobiologic products; NorthStar cervical facet fusion and Flash navigation lumbar facet fusion.
-
In August 2021, Bioventus, a US-based orthobiologics company, announced the acquisition of CartiHeal, an Israeli medical tech company.
Scope of the Report
Attributes |
Details |
Years Considered |
Historical data – 2018-2021 |
Base Year – 2021 |
|
Forecast – 2022 – 2028 |
|
Facts Covered |
Revenue in USD Billion |
Market Coverage |
U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, UAE, South Africa, Saudi Arabia |
Product Service/Segmentation |
By Product, By Application, By End User, By Region |
Key Players |
Arthrex Inc., Seaspine Holdings Corporation, Sanofi, Bone Support, DePuy Synthes, Integra Lifesciences, Globus Medical Inc., NuVasive Inc., Terumo Corporation, Medtronic PLC, Stryker Corporation, Zimmer Biomet, Pioneer Surgical Technology, Smith & Nephew plc, Bioventus LLC, Orthofix, Inc., Genzyme, Bone Biologics, Corp., Osiris Therapeutics, Inc., and other prominent players. |
By Product
-
Viscosupplementation Products
-
Demineralized Bone Matrices
-
Synthetic Orthobiologics
-
Bone Morphogenic Protein
-
Allografts
-
Plasma-Rich Protein
-
Bone Marrow Aspirate Concentrate
By Application
-
Osteoarthritis and Degenerative Arthritis
-
Spinal Fusion
-
Soft-Tissue Injuries
-
Fracture Recovery
-
Maxillofacial and Dental Applications
By End User
-
Hospitals, Orthopedic Clinics, & Ambulatory Care Centers
-
Research & Academic Institutes
-
Dental Clinics and Facilities
By Region
-
North America
-
Europe
-
Asia-Pacific (APAC)
-
Latin America (LATAM)
-
Middle East & Africa (MEA)
- Research Framework
- Research Objective
- Product Overview
- Market Segmentation
- Research Methodology
- Qualitative Research
- Primary & Secondary Research
- Quantitative Research
- Market Breakdown & Data Triangulation
- Secondary Research
- Primary Research
- Breakdown of Primary Research Respondents, By Region
- Assumption & Limitation
- Qualitative Research
- Executive Summary
- Global Orthobiologics Market Insights
- Industry Value Chain Analysis
- DROC Analysis
- Growth Drivers
- Restraints
- Opportunities
- Challenges
- Technological Landscape/Recent Development
- Regulatory Framework
- Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Global Orthobiologics Market Overview
- Market Size & Forecast by Value, 2018-2028
- By Value (USD Million)
- Market Share & Forecast
- By Product
- Demineralized Bone Matrix (DBM)
- Allograft
- Bone Morphogenetic Protein (BMP)
- Viscosupplementation Products
- Synthetic Bone Substitutes
- Others
- By Application
- Osteoarthritis & Degenerative Arthritis
- Spinal Fusion
- Fracture Recovery
- Soft Tissue Injuries
- Maxillofacial & Dental Applications
- By End User
- Hospitals & Ambulatory Centers
- Research & Academic Institute
- Dental Clinics
- By Region
- North America
- Europe
- The Asia Pacific
- Latin America
- The Middle East and Africa
- By Product
- Market Size & Forecast by Value, 2018-2028
- North America Orthobiologics Market
- Market Size & Forecast by Value, 2018-2028
- By Value (USD Million)
- Market Share & Forecast
- By Product
- By Type
- By Application
- By End User
- By Country
- United States
- Canada
- Market Size & Forecast by Value, 2018-2028
- Europe Orthobiologics Market
- Market Size & Forecast by Value, 2018-2028
- By Value (USD Million)
- Market Share & Forecast
- By Product
- By Type
- By Application
- By End User
- By Country
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Market Size & Forecast by Value, 2018-2028
- The Asia Pacific Orthobiologics Market
- Market Size & Forecast by Value, 2018-2028
- By Value (USD Million)
- Market Share & Forecast
- By Product
- By Type
- By Application
- By End User
- By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Market Size & Forecast by Value, 2018-2028
- Latin America Orthobiologics Market
- Market Size & Forecast by Value, 2018-2028
- By Value (USD Million)
- Market Share & Forecast
- By Product
- By Type
- By Application
- By End User
- By Country
- Brazil
- Mexico
- Rest of Latin America
- Market Size & Forecast by Value, 2018-2028
- The Middle East & Africa Orthobiologics Market
- Market Size & Forecast by Value, 2018-2028
- By Value (USD Million)
- Market Share & Forecast
- By Product
- By Type
- By Application
- By End User
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- Market Size & Forecast by Value, 2018-2028
- Competitive Landscape
- List of Key Players and Their Offerings
- Market Share Analysis, 2021
- Competitive Benchmarking, By Operating Parameters
- Key Strategic Development (Merger, Acquisition, Partnership.)
- Impact of Covid-19 on Global Orthobiologics Market Industry
- Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
- Arthrex Inc.
- Seaspine Holdings Corporation
- Sanofi
- Bone Support
- DePuy Synthes
- Integra Lifesciences
- Globus Medical Inc.
- NuVasive Inc.
- Terumo Corporation
- Medtronic PLC
- Stryker Corporation
- Zimmer Biomet
- Pioneer Surgical Technology
- Smith & Nephew plc
- Bioventus LLC
- Orthofix, Inc.
- Genzyme
- Bone Biologics, Corp.
- Osiris Therapeutics, Inc.
- Other prominent players
- Key Strategic Recommendations
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Figures
Figure 1 Global Orthobiologics Market Segmentation
Figure 2 Global Orthobiologics Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2021
Figure 4 Global Orthobiologics Market Size, By Value (USD Million), 2018-2028
Figure 5 Global Orthobiologics Market Share, By Product, By Value, 2018-2028
Figure 6 Global Orthobiologics Market Share, By Type, By Value, 2018-2028
Figure 7 Global Orthobiologics Market Share, By Application, By Value, 2018-2028
Figure 8 Global Orthobiologics Market Share, By End User, By Value, 2018-2028
Figure 9 Global Orthobiologics Market Share, By Region, By Value, 2018-2028
Figure 10 North America Orthobiologics Market Size, By Value (USD Million), 2018-2028
Figure 11 North America Orthobiologics Market Share, By Product, By Value, 2018-2028
Figure 12 North America Orthobiologics Market Share, By Type, By Value, 2018-2028
Figure 13 North America Orthobiologics Market Share, By Application, By Value, 2018-2028
Figure 14 North America Orthobiologics Market Share, By End User, By Value, 2018-2028
Figure 15 North America Orthobiologics Market Share, By Country, By Value, 2018-2028
Figure 16 Europe Orthobiologics Market Size, By Value (USD Million), 2018-2028
Figure 17 Europe Orthobiologics Market Share, By Product, By Value, 2018-2028
Figure 18 Europe Orthobiologics Market Share, By Type, By Value, 2018-2028
Figure 19 Europe Orthobiologics Market Share, By Application, By Value, 2018-2028
Figure 20 Europe Orthobiologics Market Share, By End User, By Value, 2018-2028
Figure 21 Europe Orthobiologics Market Share, By Country, By Value, 2018-2028
Figure 22 The Asia-Pacific Orthobiologics Market Size, By Value (USD Million), 2018-2028
Figure 23 The Asia-Pacific Orthobiologics Market Share, By Product, By Value, 2018-2028
Figure 24 The Asia-Pacific Orthobiologics Market Share, By Type, By Value, 2018-2028
Figure 25 The Asia-Pacific Orthobiologics Market Share, By Application, By Value, 2018-2028
Figure 26 The Asia-Pacific Orthobiologics Market Share, By End User, By Value, 2018-2028
Figure 27 The Asia-Pacific Orthobiologics Market Share, By Country, By Value, 2018-2028
Figure 28 Latin America Orthobiologics Market Size, By Value (USD Million), 2018-2028
Figure 29 Latin America Orthobiologics Market Share, By Product, By Value, 2018-2028
Figure 30 Latin America Orthobiologics Market Share, By Type, By Value, 2018-2028
Figure 31 Latin America Orthobiologics Market Share, By Application, By Value, 2018-2028
Figure 32 Latin America Orthobiologics Market Share, By End User, By Value, 2018-2028
Figure 33 Latin America Orthobiologics Market Share, By Country, By Value, 2018-2028
Figure 34 The Middle East & Africa Orthobiologics Market Size, By Value (USD Million), 2018-2028
Figure 35 The Middle East & Africa Orthobiologics Market Share, By Product, By Value, 2018-2028
Figure 36 The Middle East & Africa Orthobiologics Market Share, By Type, By Value, 2018-2028
Figure 37 The Middle East & Africa Orthobiologics Market Share, By Application, By Value, 2018-2028
Figure 38 The Middle East & Africa Orthobiologics Market Share, By End User, By Value, 2018-2028
Figure 39 The Middle East & Africa Orthobiologics Market Share, By Country, By Value, 2018-2028
List of Tables
Table 1 Global Orthobiologics Market Size, By Product, By Value, 2018-2028
Table 2 Global Orthobiologics Market Size, By Type, By Value, 2018-2028
Table 3 Global Orthobiologics Market Size, By Application, By Value, 2018-2028
Table 4 Global Orthobiologics Market Size, By End User, By Value, 2018-2028
Table 5 Global Orthobiologics Market Size, By Region, By Value, 2018-2028
Table 6 North America Orthobiologics Market Size, By Product, By Value, 2018-2028
Table 7 North America Orthobiologics Market Size, By Type, By Value, 2018-2028
Table 8 North America Orthobiologics Market Size, By Application, By Value, 2018-2028
Table 9 North America Orthobiologics Market Size, By End User, By Value, 2018-2028
Table 10 North America Orthobiologics Market Size, By Country, By Value, 2018-2028
Table 11 Europe Orthobiologics Market Size, By Product, By Value, 2018-2028
Table 12 Europe Orthobiologics Market Size, By Type, By Value, 2018-2028
Table 13 Europe Orthobiologics Market Size, By Application, By Value, 2018-2028
Table 14 Europe Orthobiologics Market Size, By End User, By Value, 2018-2028
Table 15 Europe Orthobiologics Market Size, By Country, By Value, 2018-2028
Table 16 The Asia-Pacific Orthobiologics Market Size, By Product, By Value, 2018-2028
Table 17 The Asia-Pacific Orthobiologics Market Size, By Type, By Value, 2018-2028
Table 18 The Asia-Pacific Orthobiologics Market Size, By Application, By Value, 2018-2028
Table 19 The Asia-Pacific Orthobiologics Market Size, By End User, By Value, 2018-2028
Table 20 The Asia-Pacific Orthobiologics Market Size, By Country, By Value, 2018-2028
Table 21 Latin America Orthobiologics Market Size, By Product, By Value, 2018-2028
Table 22 Latin America Orthobiologics Market Size, By Type, By Value, 2018-2028
Table 23 Latin America Orthobiologics Market Size, By Application, By Value, 2018-2028
Table 24 Latin America Orthobiologics Market Size, By End User, By Value, 2018-2028
Table 25 Latin America Orthobiologics Market Size, By Country, By Value, 2018-2028
Table 26 The Middle East & Africa Orthobiologics Market Size, By Product, By Value, 2018-2028
Table 27 The Middle East & Africa Orthobiologics Market Size, By Type, By Value, 2018-2028
Table 28 The Middle East & Africa Orthobiologics Market Size, By Application, By Value, 2018-2028
Table 29 The Middle East & Africa Orthobiologics Market Size, By End User, By Value, 2018-2028
Table 30 The Middle East & Africa Orthobiologics Market Size, By Country, By Value, 2018-2028
Table 31 Arthrex Inc. Company Overview
Table 32 Arthrex Inc. Financial Overview
Table 33 Seaspine Holdings Corporation Company Overview
Table 34 Seaspine Holdings Corporation Financial Overview
Table 35 Sanofi Company Overview
Table 36 Sanofi Financial Overview
Table 37 Bone Support Company Overview
Table 38 Bone Support Financial Overview
Table 39 DePuy Synthes Company Overview
Table 40 DePuy Synthes Financial Overview
Table 41 Integra Lifesciences Company Overview
Table 42 Integra Lifesciences Financial Overview
Table 43 NuVasive Inc. Company Overview
Table 44 NuVasive Inc. Financial Overview
Table 45 Globus Medical Inc. Company Overview
Table 46 Globus Medical Inc. Financial Overview
Table 47 Terumo Corporation Company Overview
Table 48 Terumo Corporation Financial Overview
Table 49 Medtronic PLC Company Overview
Table 50 Medtronic PLC Financial Overview
Table 51 Stryker Corporation Company Overview
Table 52 Stryker Corporation Financial Overview
Table 53 Zimmer Biomet Company Overview
Table 54 Zimmer Biomet Financial Overview
Table 55 Pioneer Surgical Technology Company Overview
Table 56 Pioneer Surgical Technology Financial Overview
Table 57 Smith & Nephew plc Company Overview
Table 58 Smith & Nephew plc Financial Overview
Table 59 Bioventus LLC Company Overview
Table 60 Bioventus LLC Financial Overview
Table 61 Orthofix Company Overview
Table 62 Orthofix Financial Overview
Table 63 Genzyme Company Overview
Table 64 Genzyme Financial Overview
Table 65 Bone Biologics, Corp. Company Overview
Table 66 Bone Biologics, Corp. Financial Overview
Table 67 Osiris Therapeutics Company Overview
Table 68 Osiris Therapeutics Financial Overview
Market Segmentation
By Product
- Viscosupplementation Products
- Demineralized Bone Matrices
- Synthetic Orthobiologics
- Bone Morphogenic Protein
- Allografts
- Plasma-Rich Protein
- Bone Marrow Aspirate Concentrate
By Application
- Osteoarthritis and Degenerative Arthritis
- Spinal Fusion
- Soft-Tissue Injuries
- Fracture Recovery
- Maxillofacial and Dental Applications
By End User
- Hospitals, Orthopedic Clinics, & Ambulatory Care Centers
- Research & Academic Institutes
- Dental Clinics and Facilities
By Region
- North America
- Europe
- Asia-Pacific (APAC)
- Latin America (LATAM)
- Middle East & Africa (MEA)
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.